07.02.2013 Views

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Posters, Tuesday and Wednesday<br />

Index of Poster Presenters cont’d<br />

22P39<br />

Association of Self-Reported Jo<strong>in</strong>t Pa<strong>in</strong> and Motion Limitation<br />

with Cl<strong>in</strong>ical Range of Motion Assessment <strong>in</strong> Patients with<br />

Hemophilia A<br />

Zhou Z-Y1 , Johnson K1 , Koerper M2 , Wu J1 , Curtis R3 , Riske<br />

B4 , Forsberg A5 , Ullman M6 , Lou M1 1 2 University of Southern California, CA, U.S.A., University of<br />

California, San Francisco, CA, U.S.A., 3Department of Health<br />

Services, Richmond, CA, U.S.A., 4University of Colorado<br />

Denver, CO, U.S.A., 5UMass Memorial Hospital, MA, U.S.A.,<br />

6University of Texas Health Science at Houston, TX, U.S.A.<br />

OTHER<br />

24P05<br />

Venous Thromboembolism <strong>in</strong> Males with a Severe Form of<br />

Hemophilia: The Experience of One Centre<br />

Dulíèek P1 , Malý J1 , Pecka M1 , Beránek M2 1Internal Department, Division of Hematology and<br />

2Department of Cl<strong>in</strong>ical Biochemistry, Charles University,<br />

Hradec Králové, Czech Republic<br />

24P06<br />

Immunologic Reactivity <strong>in</strong> Patients with Hemophilia<br />

Kazimova M<br />

Azerbaijan State Advanced Tra<strong>in</strong><strong>in</strong>g Institute, Baku,<br />

Azerbaijan<br />

24P07<br />

EUHASS: The First 12 Months of a European Adverse Event<br />

Report<strong>in</strong>g System for Hemophilia<br />

Markis, M<br />

Royal Hallamshire Hospital, Sheffield, United K<strong>in</strong>gdom<br />

24P08<br />

Apply<strong>in</strong>g New Technologies When Tak<strong>in</strong>g Care of Hemophilia<br />

Patients<br />

Montaño Mejía CA<br />

Bogota, Colombia<br />

24P09<br />

Thromboelastography Reveals K<strong>in</strong>etics of LPS-Induced<br />

Coagulopathy and Correlates to Fetal Outcome <strong>in</strong> a Rat<br />

Model of Pregnancy Complications<br />

Othman M, Renaud S, Quirt J, MacDonald-Goodfellow S,<br />

and Graham C<br />

Laurentian University- St Lawrence College Collaborative<br />

BScN <strong>Program</strong>, K<strong>in</strong>gston, ON, Canada<br />

78<br />

24P10<br />

Trauma-Related Bleed<strong>in</strong>g Complications <strong>in</strong> South African<br />

Hemophilia Patients (2000–2009): Cl<strong>in</strong>ical Presentation,<br />

Management, and Prognostic Factors<br />

Sissolak G 1 , Dippenaar A 1 , Cruickshank A-L 2 , Desai F 3 ,<br />

Karabus C, McDonald A 2<br />

Tygerberg Hospital Haemophilia Comprehensive Treatment<br />

Centre 1 , Groote Schuur Hospital Haemophilia Comprehensive<br />

Treatment Centre 2 , Red Cross War Memorial Children’s<br />

Hospital Haemophilia Comprehensive Treatment Centre 3 ,<br />

Cape Town, South Africa<br />

OTHER TREATMENT MODALITIES<br />

25P02<br />

MRI and US: Look<strong>in</strong>g for a Precocious Diagnosis of Jo<strong>in</strong>t<br />

Diseases<br />

Aparisi Rodriguez F, Querol Fuentes F, Beltran Mayor J,<br />

Cifrian Cavada C, Ramirez Latorre O, Gomez J<br />

Hospital La Fe, Valencia, Spa<strong>in</strong><br />

25P03<br />

Aga<strong>in</strong>st the Prejudice - Ethic Use of Factor VIII Products <strong>in</strong><br />

the Adolescent Population Dur<strong>in</strong>g Social Interventions &<br />

Hemophiliac Camps<br />

Balliel W1 , Hamulyak K2 1 2 AUGMENTO - HTC and Department of Hematology,<br />

Maastricht UMC, Maastricht, the Netherlands<br />

25P04<br />

Case Report on Intra-Articular Hyaluronic Acid <strong>in</strong> the<br />

Treatment of Chronic Hemophilic Arthropathy <strong>in</strong> a Patient<br />

with Severe Hemophilia A<br />

Chan R, Osip J, Baumann K, Red<strong>in</strong>g M<br />

University of M<strong>in</strong>nesota Medical Center, Fairview, Center for<br />

Bleed<strong>in</strong>g and Clott<strong>in</strong>g Disorders, M<strong>in</strong>neapolis, MN, U.S.A.<br />

25P05<br />

Manag<strong>in</strong>g Hemorrhagic and Thromboembolic Risk <strong>in</strong> Patients<br />

with Acquired Hemophilia<br />

Coppola A, Tufano A, Cim<strong>in</strong>o E, Guida A, Battipaglia G, Di<br />

M<strong>in</strong>no MND<br />

Regional Reference Centre for Coagulation Disorders,<br />

Federico II University, Naples, Italy<br />

25P06<br />

Procoagulant Activity of Sulfated Polysaccharides<br />

Dockal M, Knappe S, Panholzer E, Palige M, Ehrlich H,<br />

Scheifl<strong>in</strong>ger F<br />

Baxter Innovations GmbH, Orth Donau, Austria

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!